We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
-4.35%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$233B
AUM Growth
-$27.8B
Cap. Flow
-$12.3B
Cap. Flow %
-5.26%
Top 10 Hldgs %
23.23%
Holding
2,904
New
60
Increased
1,374
Reduced
786
Closed
124

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$646M
2
ADP icon
Automatic Data Processing
ADP
+$510M
3
BIDU icon
Baidu
BIDU
+$349M
4
TSLA icon
Tesla
TSLA
+$320M
5
NVDA icon
NVIDIA
NVDA
+$261M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Healthcare 13.27%
3 Financials 12.05%
4 Consumer Discretionary 11.3%
5 Communication Services 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CGEN icon
2626
Compugen
CGEN
$228M
$200K ﹤0.01%
62,030
FDMT icon
2627
4D Molecular Therapeutics
FDMT
$562M
$199K ﹤0.01%
13,182
QTTB icon
2628
Q32 Bio
QTTB
$464M
$199K ﹤0.01%
3,640
CLVS
2629
DELISTED
Clovis Oncology, Inc.
CLVS
$198K ﹤0.01%
98,191
URGN icon
2630
UroGen Pharma
URGN
$2.29B
$195K ﹤0.01%
22,400
SFL icon
2631
SFL Corp
SFL
$1.61B
$195K ﹤0.01%
19,124
-4,576
-19% -$42.2K
BARK icon
2632
BARK
BARK
$101M
$195K ﹤0.01%
+2,630
New +$187K
CTLP
2633
DELISTED
Cantaloupe
CTLP
$193K ﹤0.01%
28,448
CMBT
2634
CMB.TECH NV
CMBT
$4.73B
$189K ﹤0.01%
17,898
MDXG icon
2635
MiMedx Group
MDXG
$633M
$189K ﹤0.01%
40,062
BCOV
2636
DELISTED
Brightcove, Inc.
BCOV
$186K ﹤0.01%
23,800
YMAB
2637
DELISTED
Y-mAbs Therapeutics
YMAB
$185K ﹤0.01%
15,600
BODI icon
2638
The Beachbody Company
BODI
$74.8M
$184K ﹤0.01%
1,622
+80
+5% +$8.15K
DOMA
2639
DELISTED
Doma Holdings, Inc.
DOMA
$183K ﹤0.01%
3,371
EGLX
2640
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$182K ﹤0.01%
75,350
-92,746
-55% -$247K
CRIS icon
2641
Curis
CRIS
$7.83M
$182K ﹤0.01%
191
GBIO
2642
DELISTED
Generation Bio
GBIO
$181K ﹤0.01%
2,467
LXRX icon
2643
Lexicon Pharmaceuticals
LXRX
$1.1B
$175K ﹤0.01%
83,874
API
2644
Agora
API
$377M
$172K ﹤0.01%
17,300
-309,670
-95% -$3.48M
UP icon
2645
Wheels Up
UP
$198M
$171K ﹤0.01%
276
TSVT
2646
DELISTED
2seventy bio
TSVT
$171K ﹤0.01%
10,033
RUBY
2647
DELISTED
Rubius Therapeutics, Inc
RUBY
$168K ﹤0.01%
30,575
BNFT
2648
DELISTED
Benefitfocus, Inc.
BNFT
$166K ﹤0.01%
13,124
-2,629
-17% -$28.1K
STRO icon
2649
Sutro Biopharma
STRO
$421M
$165K ﹤0.01%
+2,010
New +$191K
SPWH icon
2650
Sportsman's Warehouse
SPWH
$46M
$165K ﹤0.01%
15,400

Similar funds

UBS AM's Q1 2022 Portfolio in Review

As of Q1 2022, UBS AM held 2,904 positions worth $233B, down 11% from $261B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

UBS AM withdrew a net $12.3B in Q1 2022, closing 124 positions and reducing 786 holdings. Its most notable exit was Xilinx Inc, an estimated $758M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS AM opened a new position in Baidu worth $306M.

  • UBS AM's largest Q1 2022 buy was Baidu: 2,316,525 shares worth $306M.
  • UBS AM added most to Advanced Micro Devices in Q1 2022, an estimated $646M increase.
  • UBS AM's biggest Q1 2022 reduction was Shopify, cutting an estimated $568M.
  • UBS AM fully exited Xilinx Inc in Q1 2022, selling an estimated $758M.
  • UBS AM's ten largest holdings make up 23% of its $233B portfolio in Q1 2022.
  • UBS AM opened 60 new positions and closed 124 in Q1 2022.
  • UBS AM's portfolio value fell 11% quarter-over-quarter to $233B.

Based on UBS AM's 13F filing for Q1 2022, filed 16 May 2022.